This article tends to explain the basics information regarding CERVICAL CANCER VACCINE , Human Papillomavirus Vaccine. Human papillomavirus is a sexually transmitted infection known to be associated with cervical cancer.
Three vaccines namely Cervarix , Gardasil and Gardasil 9 have been approved by the Food and Drug Administration (FDA) in the U.S. Cervarix is used for girls only, while Gardasil can be used for both girls and boys.
Most if not all cases of cervical cancer are caused by the human papilloma virus. HPV types, 16 and 18, are the cause for roughly 70 percent of all cases. In case of Anal cancer up to 95 percent of all anal cancers are caused by HPV with the most commonly involved strain being HPV type 16
Cervical , vaginal and vulvar cancer can be prevented if these vaccines can be given before a girl gets exposed to the virus. Gardasil vaccines cover 4 strains as compared to 2 by cervarix and is the new vaccine in the market which can be preventive for genital warts and anal cancer in both women and men. HPV has also been linked to some cancers in the mouth and throat, so this vaccine would likely be offering protection against such cancers, too.
CERVICAL CANCER VACCINE, Human Papillomavirus Vaccine includes the cervarix vaccine which is a recombinant vaccine prepared from L1 protein of the HPV strains namely types 16 and 18.
Women who get vaccinated after getting sexually active may not reap the full benefits of this vaccine as they would already be exposed to the HPV virus in a majority of the cases.
Remember, the HPV vaccine is not effective in treating or countering an HPV infection or its complications. Its role is purely preventive. Even if you are sexually active, vaccination should be done because one is not sure which strain may be the infecting agent.
Cervical cancer screening is still continued despite getting vaccinated for the most common strains associated with cervical cancer as it covers some but not all strains.
HPV2 or cervarix vaccine recommendation is a 0.5 ml I.M administration in deltoid region at months 0, 1 and 6 for a total of 3 doses. It is indicated for girls and women (9 to 26 years old). If age 26 is reached before the vaccines are completed then the remaining doses should still not be missed and completed as per schedule.
The HPV CERVICAL CANCER VACCINE should be avoided in pregnancy, active ailment, moderate to high grade fever and if you have an allergy to the contents of the vaccine.